IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
If you’re looking to outsource drug product development to a CDMO, you need a collaborative partner who will engage you deeply to understand the unique needs of your project.
From pre-formulation to commercial manufacturing and packaging, you can trust Cambrex to deliver your complex dosage forms with the perfect combination of technology, expertise, and collaboration.
We are equipped to take on projects at any size or scale, offering established pediatric formulation and development expertise and to-scale manufacturing capabilities.
Biopharma companies at all stages of development, rely on our expertise and broad capabilities to produce the clinical trial supply of drug products they need, when they need them.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
Cambrex offers a comprehensive suite of testing services for complex biopharmaceuticals including standalone analytical R&D, method validation, release testing, ICH stability, and routine QC testing.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
Process monitoring tools are essential throughout manufacturing, but the complexity of drug development makes it challenging to integrate robust process analysis into every phase without encountering logistical or financial challenges. At-line and off-line sampling techniques can be useful, but they are limited because the analysis they provide is conducted separately from the process. In-line analytics encompass techniques that monitor the product flow directly and therefore provide more accurate data.
Either way, Cambrex works closely with your development team to implement the appropriate monitoring strategy for your program needs, whether you are pursuing batch or continuous flow programs. We have the experts and the equipment to provide advanced monitoring, including ReactIR™ spectroscopy, Raman spectroscopy, focused beam reflectance measurement (FBRM), nuclear magnetic resonance (NMR) spectroscopy and more. Our general approach is to define critical process parameters for small-scale development batches, then scale back in-situ reaction monitoring for larger manufacturing runs, at which time we rely on general parametric data such as temperature, pressure and pH.
Integrated data acquisition capabilities are available at our High Point, NC, facility, which houses our continuous flow development lab, extensive analytics equipment and a cadre of analytical research development and process chemists who collaborate seamlessly to ensure the success of your project. Our acquisition of Snapdragon Chemistry also expands our capacity to offer an array of in-line and at-line process analytical technologies (PAT) for real-time monitoring and control. For example, Snapdragon Chemistry’s Sample Relay System (SRS™) enables online automated sampling and liquid chromatography analysis, and its LabOS™ monitoring and automation platform connects seamlessly with pumps, meters, PAT and more to support data-rich experimentation and flexible automation.
We love challenges, and we would like to learn more about your in-line monitoring challenges. Contact us to discuss your project.